WR
RGEN icon

Watson Rebecca’s Repligen RGEN Stock Holding History

Watson Rebecca’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-700
Closed -$87K – 295
2020
Q2 		$87K Buy
+700
New +$82.3K 0.05% 121

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Watson Rebecca's RGEN Position: Q3 2020 in Review

Watson Rebecca sold out of Repligen (RGEN) in Q3 2020, closing a stake of 700 shares — an estimated $87K sold.

Watson Rebecca first reported a position in RGEN in Q2 2020 and held it in 1 quarter. The position peaked at $87K in Q2 2020. 390 funds tracked by Wall St. Rank hold RGEN as of Q3 2020.

  • Watson Rebecca reported no remaining Repligen position as of Q3 2020 after selling out during the quarter.
  • Watson Rebecca sold 700 Repligen shares in Q3 2020, an estimated $87K.
  • Watson Rebecca first reported a position in Repligen in Q2 2020 and held it in 1 quarter.
  • Watson Rebecca's Repligen position peaked at $87K in Q2 2020.
  • 390 funds tracked by Wall St. Rank held Repligen as of Q3 2020.

Based on Watson Rebecca's 13F filing for Q3 2020, filed 22 Oct 2020.